PHASE-II TRIALS OF CISPLATIN AND PIPERAZINEDIONE AS SINGLE AGENTS IN THE TREATMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引:0
作者
THIGPEN, JT
BLESSING, JA
FOWLER, WC
HATCH, K
机构
[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED,DIV ONCOL,JACKSON,MS 39216
[2] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT OBSTET & GYNECOL,JACKSON,MS 39216
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[4] UNIV N CAROLINA,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,CHAPEL HILL,NC 27514
[5] UNIV ALABAMA,DIV GYNECOL ONCOL,BIRMINGHAM,AL 35294
来源
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 09期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1097 / 1100
页数:4
相关论文
共 50 条
[31]   Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: A gynecologic oncology group study [J].
Morris, M ;
Blessing, JA ;
Monk, BJ ;
McGehee, R ;
Moore, DH .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3340-3344
[32]   Phase II trial of bevacizumab in the treatment of recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study [J].
Monk, B. J. ;
Sill, M. W. ;
Burger, R. A. ;
Gray, H. J. ;
Buekers, T. E. ;
Roman, L. D. .
GYNECOLOGIC ONCOLOGY, 2008, 108 (03) :S21-S22
[33]   PHASE-II TRIAL OF IFOSFAMIDE AND MESNA IN PATIENTS WITH ADVANCED OR RECURRENT SQUAMOUS CARCINOMA OF THE CERVIX WHO HAD NEVER RECEIVED CHEMOTHERAPY - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
SUTTON, GP ;
BLESSING, JA ;
MCGUIRE, WP ;
PATTON, T ;
LOOK, KY .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (03) :805-807
[34]   PHASE-II TRIAL OF CISPLATIN AS 2-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
THIGPEN, JT ;
BLESSING, JA ;
LAGASSE, LD ;
DISAIA, PJ ;
HOMESLEY, HD .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (03) :253-256
[35]   PHASE-II STUDY OF FLUDARABINE PHOSPHATE FOR THE TREATMENT OF ADVANCED NON-SMALL CELL-CARCINOMA OF THE LUNG - A SOUTHWEST ONCOLOGY GROUP-STUDY [J].
WEISS, GR ;
CROWLEY, J ;
VONHOFF, DD ;
TAYLOR, SA ;
BELT, RJ ;
COLTMAN, CA ;
HYNES, HE ;
COSTANZI, JJ .
CANCER TREATMENT REPORTS, 1986, 70 (09) :1123-1124
[36]   ECHINOMYCIN (NSC 526417) IN RECURRENT AND METASTATIC NONSQUAMOUS CELL-CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP [J].
MUSS, HB ;
BLESSING, JA ;
HANJANI, P ;
MALFETANO, JH ;
KEMP, GM ;
WEBSTER, K .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (04) :363-364
[37]   A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix A Gynecologic Oncology Group Study [J].
Schilder, Russell J. ;
Sill, Michael W. ;
Lee, Yi-Chun ;
Mannel, Robert .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) :929-933
[38]   A PHASE-II STUDY OF CARBOPLATIN AND CISPLATIN IN ADVANCED OR RECURRENT SQUAMOUS CARCINOMA OF THE UTERINE CERVIX [J].
MORRIS, M ;
GERSHENSON, DM ;
BURKE, TW ;
MITCHELL, MF ;
LEVENBACK, C ;
ATKINSON, N ;
WHARTON, JT .
GYNECOLOGIC ONCOLOGY, 1994, 53 (02) :234-238
[39]   A PHASE-II EVALUATION OF MITOLACTOL IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY [J].
STEHMAN, FB ;
BLESSING, JA ;
MCGEHEE, R ;
BARRETT, RJ .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) :1892-1895
[40]   PHASE-II TRIAL OF DICHLOROMETHOTREXATE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY [J].
ROBERTS, JA ;
BLESSING, JA ;
MCGEHEE, R ;
BEECHAM, J ;
HOMESLEY, HD .
CANCER TREATMENT REPORTS, 1987, 71 (12) :1295-1296